The Automation Partnership's Advanced Projects Group Announces Successful Collaboration with Cellectricon
Complete the form below to unlock access to ALL audio articles.
Patch clamping is the gold standard for screening ion channels in drug discovery. Currently, few commercial instruments exist for high throughput primary and secondary screening so TAP’s Advanced Projects Group of specialist engineers, software designers and biologists have worked closely with Cellectricon to produce the Dynaflow®HT System to meet this need.
The Dynaflow®HT System, which has been developed in collaboration with AstraZeneca in Sweden is now becoming commercially available and addresses the limits of existing ion channel screening equipment by combining high levels of automated throughput with data measurement.